Breaking News

Over a week ago
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Get Free Trial
Send Info
Hot Stocks
Immix Biopharma says 'on track' to dose NXC-201 patients in U.S. » 09:33
04/18/24
04/18
09:33
04/18/24
09:33
IMMX

Immix Biopharma

$2.50 /

-0.06 (-2.34%)

Immix Biopharma announced…
Available to The Fly Members Only
Breaking content available to members only. Sign up or login for access.
Create FREE Account
Over a month ago
Hot Stocks
Immix announces Memorial Sloan Kettering as lead site for NXC-201 trial » 09:49
03/20/24
03/20
09:49
03/20/24
09:49
IMMX

Immix Biopharma

$2.79 /

+ (+0.00%)

Immix Biopharma announced…
Available to The Fly Members Only
Breaking content available to members only. Sign up or login for access.
Create FREE Account
Hot Stocks
Immix Biopharma: EC grants orphan drug designation to NXC-201 » 09:39
02/07/24
02/07
09:39
02/07/24
09:39
IMMX

Immix Biopharma

$2.81 /

-0.19 (-6.33%)

Immix Biopharma announced…
Available to The Fly Members Only
Breaking content available to members only. Sign up or login for access.
Create FREE Account
Syndicate
Immix Biopharma 5.5M share priced at $2.71 » 08:04
02/06/24
02/06
08:04
02/06/24
08:04
IMMX

Immix Biopharma

$3.00 /

-0.71 (-19.14%)

Titan Partners acted as…
Available to The Fly Members Only
Breaking content available to members only. Sign up or login for access.
Create FREE Account
Syndicate
Immix Biopharma announces common stock offering, no amount given » 15:21
02/05/24
02/05
15:21
02/05/24
15:21
IMMX

Immix Biopharma

$3.85 /

+0.14 (+3.77%)

Immix Biopharma announced…
Available to The Fly Members Only
Breaking content available to members only. Sign up or login for access.
Create FREE Account
Over a quarter ago
Hot Stocks
Immix Biopharma 'applauds' FDA labeling change notification for CAR-T products » 08:38
01/24/24
01/24
08:38
01/24/24
08:38
IMMX

Immix Biopharma

$4.71 /

-0.59 (-11.13%)

Immix Biopharma announced…
Available to The Fly Members Only
Breaking content available to members only. Sign up or login for access.
Create FREE Account
Options
Three new option listings on January 24th » 08:30
01/24/24
01/24
08:30
01/24/24
08:30
IMMX

Immix Biopharma

$4.71 /

-0.59 (-11.13%)

, MYO

Myomo

$3.86 /

+0.205 (+5.61%)

, NPCE

NeuroPace

$14.26 /

-0.505 (-3.42%)

New option listings for…
Available to The Fly Members Only
Breaking content available to members only. Sign up or login for access.
Create FREE Account
Hot Stocks
Immix Biopharma reports 100% ORR for CAR-T NXC-201 in r/r AL amyloidosis » 09:39
12/11/23
12/11
09:39
12/11/23
09:39
IMMX

Immix Biopharma

$4.80 /

-0.19 (-3.81%)

Immix Biopharma announced…
Available to The Fly Members Only
Breaking content available to members only. Sign up or login for access.
Create FREE Account
Conference/Events
Immix Biopharma to hold virtual investor day » 16:00
11/29/23
11/29
16:00
11/29/23
16:00
IMMX

Immix Biopharma

$5.09 /

-0.165 (-3.14%)

Virtual Investor Day to…
Available to The Fly Members Only
Breaking content available to members only. Sign up or login for access.
Create FREE Account
Conference/Events
Immix Biopharma to hold virtual investor day » 10:16
11/29/23
11/29
10:16
11/29/23
10:16
IMMX

Immix Biopharma

$5.00 /

-0.25 (-4.76%)

Virtual Investor Day to…
Available to The Fly Members Only
Breaking content available to members only. Sign up or login for access.
Create FREE Account
Hot Stocks
Immix Biopharma announces FDA approval of IND application for NXC-201 » 09:49
11/21/23
11/21
09:49
11/21/23
09:49
IMMX

Immix Biopharma

$4.39 /

+ (+0.00%)

Immix Biopharma announced…
Available to The Fly Members Only
Breaking content available to members only. Sign up or login for access.
Create FREE Account
Hot Stocks
Immix Biopharma completes third NXC-201 engineering batch » 09:09
10/16/23
10/16
09:09
10/16/23
09:09
IMMX

Immix Biopharma

$2.99 /

-0.26 (-8.00%)

Immix Biopharma announced…
Available to The Fly Members Only
Breaking content available to members only. Sign up or login for access.
Create FREE Account
Hot Stocks
Immix Biopharma announces complete response in patient in NXC-201 trial » 09:18
10/03/23
10/03
09:18
10/03/23
09:18
IMMX

Immix Biopharma

$4.32 /

+0.94 (+27.81%)

Immix Biopharma announced…
Available to The Fly Members Only
Breaking content available to members only. Sign up or login for access.
Create FREE Account
Hot Stocks
Immix Biopharma announces 72-patient NXC-201 clinical data » 08:16
10/02/23
10/02
08:16
10/02/23
08:16
IMMX

Immix Biopharma

$3.39 /

-0.25 (-6.87%)

Immix Biopharma announced…
Available to The Fly Members Only
Breaking content available to members only. Sign up or login for access.
Create FREE Account
On The Fly
Fly Intel: After-Hours Movers » 18:25
09/25/23
09/25
18:25
09/25/23
18:25
PROF

Profound Medical

$9.92 /

+ (+0.00%)

, GRIN

Grindrod Shipping

$9.35 /

+0.34 (+3.77%)

, SPRY

ARS Pharmaceuticals

$3.60 /

-0.38 (-9.55%)

, CURV

Torrid

$1.27 /

+ (+0.00%)

, SCVL

Shoe Carnival

$23.40 /

+0.245 (+1.06%)

, MEIP

MEI Pharma

$7.50 /

-0.2 (-2.60%)

, LQDA

Liquidia

$6.28 /

-0.125 (-1.95%)

, LGND

Ligand

$58.84 /

-0.17 (-0.29%)

, THO

Thor Industries

$94.82 /

+1.89 (+2.03%)

, COTY

Coty

$11.78 /

-0.1 (-0.84%)

, IMMX

Immix Biopharma

$2.96 /

-0.46 (-13.45%)

Check out this evening's…

Open Full Text

Syndicate
Immix Biopharma files to sell 5.15M shares of common stock for holders 16:18
09/25/23
09/25
16:18
09/25/23
16:18
IMMX

Immix Biopharma

$2.96 /

-0.46 (-13.45%)

 
Hot Stocks
Immix Biopharma receives orphan drug designation for NXC-201 » 08:57
09/21/23
09/21
08:57
09/21/23
08:57
IMMX

Immix Biopharma

$2.97 /

-0.295 (-9.04%)

Immix Biopharma announced…
Available to The Fly Members Only
Breaking content available to members only. Sign up or login for access.
Create FREE Account
Hot Stocks
Immix Biopharma's Nexcella completes 2nd NXC-201 engineering batch » 09:24
09/19/23
09/19
09:24
09/19/23
09:24
IMMX

Immix Biopharma

$2.62 /

-0.02 (-0.76%)

Immix Biopharma announced…
Available to The Fly Members Only
Breaking content available to members only. Sign up or login for access.
Create FREE Account
Hot Stocks
Immix Biopharma appoints Suzanne Lentzsch to Nexcella SAB » 08:41
09/01/23
09/01
08:41
09/01/23
08:41
IMMX

Immix Biopharma

$2.05 /

+0.08 (+4.06%)

Immix Biopharma announced…
Available to The Fly Members Only
Breaking content available to members only. Sign up or login for access.
Create FREE Account
Hot Stocks
Immix Biopharma receives orphan drug designation for NXC-201 » 08:38
08/23/23
08/23
08:38
08/23/23
08:38
IMMX

Immix Biopharma

$1.78 /

-0.18 (-9.18%)

Immix Biopharma announced…
Available to The Fly Members Only
Breaking content available to members only. Sign up or login for access.
Create FREE Account
Hot Stocks
Immix Biopharma appoints Heather Landau to Nexcella SAB » 09:22
08/18/23
08/18
09:22
08/18/23
09:22
IMMX

Immix Biopharma

$1.61 /

-0.16 (-9.04%)

Immix Biopharma announced…
Available to The Fly Members Only
Breaking content available to members only. Sign up or login for access.
Create FREE Account
Hot Stocks
Immix announces additional NXC-201 AL Amyloidosis data to be presented » 09:10
08/16/23
08/16
09:10
08/16/23
09:10
IMMX

Immix Biopharma

$1.84 /

+0.03 (+1.66%)

Immix Biopharma announced…
Available to The Fly Members Only
Breaking content available to members only. Sign up or login for access.
Create FREE Account
Hot Stocks
Immix Biopharma second interim clinical trial data readout for IMX-110 » 09:44
07/17/23
07/17
09:44
07/17/23
09:44
IMMX

Immix Biopharma

$2.31 /

+ (+0.00%)

, BGNE

BeiGene

$196.38 /

+0.04 (+0.02%)

Immix Biopharma (IMMX)…
Available to The Fly Members Only
Breaking content available to members only. Sign up or login for access.
Create FREE Account
Hot Stocks
Immix's Nexcella completes initial NXC-201 engineering batch at U.S. site » 09:49
07/10/23
07/10
09:49
07/10/23
09:49
IMMX

Immix Biopharma

$2.30 /

+0.065 (+2.91%)

Nexcella announced the…
Available to The Fly Members Only
Breaking content available to members only. Sign up or login for access.
Create FREE Account
Hot Stocks
Immix Biopharma's Nexcella completes pre-IND meeting with FDA on NXC-201 » 09:50
06/26/23
06/26
09:50
06/26/23
09:50
IMMX

Immix Biopharma

$2.55 /

-0.03 (-1.16%)

Nexcella has completed a…
Available to The Fly Members Only
Breaking content available to members only. Sign up or login for access.
Create FREE Account
Hot Stocks
Immix Biopharma's Nexcella commences NXC-201 engineering batches » 09:56
05/26/23
05/26
09:56
05/26/23
09:56
IMMX

Immix Biopharma

$1.52 /

-0.07 (-4.40%)

Nexcella announced the…
Available to The Fly Members Only
Breaking content available to members only. Sign up or login for access.
Create FREE Account
Hot Stocks
Immix Biopharma announces NXC-201 clinical results at ASGCT » 16:41
05/21/23
05/21
16:41
05/21/23
16:41
IMMX

Immix Biopharma

$1.66 /

-0.19 (-10.27%)

Immix Biopharma announced…
Available to The Fly Members Only
Breaking content available to members only. Sign up or login for access.
Create FREE Account
Hot Stocks
Immix Biopharma announces early interim clinical trial data on IMX-110 » 08:10
05/03/23
05/03
08:10
05/03/23
08:10
IMMX

Immix Biopharma

$2.90 /

+0.15 (+5.45%)

Immix Biopharma announced…
Available to The Fly Members Only
Breaking content available to members only. Sign up or login for access.
Create FREE Account
Hot Stocks
Immix says Bristol-Myers exercises option, enters license for TCR-T candidate » 07:05
05/01/23
05/01
07:05
05/01/23
07:05
IMMX

Immix Biopharma

$2.45 /

+0.16 (+6.99%)

, BMY

Bristol Myers

$66.78 /

-0.81 (-1.20%)

Immatics (IMMX) announced…
Available to The Fly Members Only
Breaking content available to members only. Sign up or login for access.
Create FREE Account

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.